INNOVAKINE

Innovakine was founded in 2019 based on technology co-invented by Brad Nelson PhD of BC Cancer/Provincial Health Services Authority, Martin Boulanger PhD of the University of Victoria, and Zymeworks Inc., a clinical-stage biotechnology company. Innovakine has secured exclusive, worldwide rights to use the engineered cytokine-receptor technology in all fields of medicine and research... Innovakine Therapeutics Inc. is an innovative platform technology company developing novel molecular tools to revolutionize cell-based therapies for cancer, infectious disease, autoimmunity and regenerative medicine... Using cutting-edge protein and cell engineering approaches, Innovakine has developed a molecular toolkit of cytokine/receptor pairs designed to improve the efficacy and safety of cell-based therapies. This proprietary platform technology will allow clinicians to send exclusive, customized signals to immune cells and other cell types anywhere in the body, with broad clinical applications..

Also known as: Innovakine Therapeutics, Innovakine Therapeutics Inc.